Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (519)

« Back to Publications

Implicit learning across varying temporal scales in individuals with and without mood instability

Atkinson LZ. et al, (2026), Journal of Affective Disorders, 395, 120728 - 120728

Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention

Taquet M. et al, (2025), npj Vaccines, 10

Neural signatures of risk-taking adaptions across health, bipolar disorder, and lithium treatment

Scholl J. et al, (2025), Molecular Psychiatry, 30, 2955 - 2965

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections

Taquet M. et al, (2025), npj Vaccines, 10

Identifying mood instability and circadian rest-activity patterns using digital remote monitoring and actigraphy in participants at risk for bipolar disorder

Panchal P. et al, (2025)

Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

Wood GK. et al, (2025), Nature Medicine, 31, 245 - 257

Can liaison neurology add value to patient care within a mental health setting?

Ward JH. et al, (2025), The British Journal of Psychiatry, 226, 47 - 48

Identification and characterization of human KALRN mRNA and Kalirin protein isoforms

Mould AW. et al, (2024), Cerebral Cortex, 34

The recombinant shingles vaccine is associated with lower risk of dementia

Taquet M. et al, (2024), Nature Medicine, 30, 2777 - 2781

Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

Taquet M. et al, (2024), The Lancet Psychiatry, 11, 696 - 708

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial

de Cates AN. et al, (2024), The British Journal of Psychiatry, 225, 371 - 378

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study

De Giorgi R. et al, (2024), eClinicalMedicine, 74, 102726 - 102726

Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

Michael BD. et al, (2024), Nature Communications, 15

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

Taquet M. et al, (2023), Brain Communications, 6

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

Michael BD. et al, (2023), Nature Communications, 14

Load More

1
2
3
4
5
6
7
...
»